(Q37368168)

20 August 2017

1 reference

title

Clinical pharmacokinetics of propafenone (English)

1 reference

20 August 2017

1 reference

Hii JT

1

1 reference

20 August 2017

Duff HJ

series ordinal

2

1 reference

20 August 2017

Burgess ED

series ordinal

3

1 reference

20 August 2017

1 July 1991

1 reference

Clinical Pharmacokinetics

20 August 2017

1 reference

20 August 2017

21

1 reference

20 August 2017

1

1 reference

20 August 2017

1-10

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199121010-00001

20 August 2017

0 references

cites work

Aggravation of electrically provoked ventricular tachycardia during treatment with propafenone.

1 reference

12 December 2020

Correlation between serum concentration and pharmacological effect on atrioventricular conduction time of the antiarrhythmic drug propafenone

1 reference

12 December 2020

Comparative pharmacokinetics and clinical pharmacology of propafenone enantiomers after oral administration to man

1 reference

12 December 2020

Demonstration of beta adrenoceptor blockade by propafenone hydrochloride: clinical pharmacologic, radioligand binding and adenylate cyclase activation studies

1 reference

12 December 2020

Propafenone disposition kinetics in cardiac arrhythmia

1 reference

12 December 2020

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

12 December 2020

Drug binding to human alpha-1-acid glycoprotein in health and disease

1 reference

12 December 2020

Electrophysiological and Antiarrhythmic Properties of Propafenon in Isolated Cardiac Preparations

1 reference

12 December 2020

Distribution of propafenone and its active metabolite, 5-hydroxypropafenone, in human tissues

1 reference

12 December 2020

Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences

1 reference

12 December 2020

Electrophysiological effects of 5-hydroxypropafenone on guinea pig ventricular muscle fibers.

1 reference

12 December 2020

Influence of protein binding on the myocardial uptake and pharmacodynamics of propafenone

1 reference

12 December 2020

[Profound granulocytopenia in a patient treated with propafenon ]

1 reference

12 December 2020

Propafenone, a review of its profile

1 reference

12 December 2020

Food increases the bioavailability of propafenone

1 reference

12 December 2020

Electrophysiologic and hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia

1 reference

12 December 2020

The multiple modes of action of propafenone

1 reference

12 December 2020

Propafenone disposition in renal insufficiency and renal failure

1 reference

12 December 2020

Interaction between warfarin and propafenone in healthy volunteer subjects

1 reference

12 December 2020

Effects of coadministration of propafenone on the pharmacokinetics of digoxin in healthy volunteer subjects

1 reference

12 December 2020

Propafenone--a new antiarrhythmic drug

1 reference

12 December 2020

Atrial flutter in patients treated for atrial fibrillation with propafenone

1 reference

12 December 2020

Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect

1 reference

12 December 2020

Comparison of the pharmacodynamic effects of intravenous and oral propafenone

1 reference

12 December 2020

Propafenone: a new agent for ventricular arrhythmia

1 reference

12 December 2020

Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up

1 reference

12 December 2020

Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia

1 reference

12 December 2020

Clinical pharmacology of propafenone

1 reference

12 December 2020

Plasma level and effectiveness of propafenone and its organ distribution (author's transl)

1 reference

12 December 2020

Oxidation phenotype--a major determinant of metoprolol metabolism and response

1 reference

12 December 2020

Interaction between propranolol and propafenone in healthy volunteers

1 reference

12 December 2020

Influence of hepatic dysfunction on the pharmacokinetics of propafenone.

1 reference

12 December 2020

Lack of clinically significant beta-blocking effect of propafenone

1 reference

12 December 2020

1 reference

12 December 2020

Myocardial uptake kinetics and pharmacodynamics of propafenone in the isolated perfused rabbit heart

1 reference

12 December 2020

Propafenone for refractory ventricular arrhythmias: correlation with drug plasma levels during long-term treatment

1 reference

12 December 2020

Inhibiton of $$\dot V_{\max } $$ of the action potential by propafenone and its voltage-, time- and pH-dependence in mammalian ventricular myocardium

1 reference

12 December 2020

Electrophysiological effects of propafenone in untreated and propafenone-pretreated guinea-pig atrial and ventricular muscle fibres

1 reference

12 December 2020

Diphenylhydantoin Metabolism in Uremia

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group

1 reference

12 December 2020

Drug interaction between propafenone and metoprolol

1 reference

12 December 2020

The metabolic fate of 2H-labelled propafenone in man

1 reference

12 December 2020

Tonic and phasic INa blockade by antiarrhythmics. Different properties of drug binding to fast sodium channels as judged from Vmax studies with propafenone and derivatives in mammalian ventricular myocardium

1 reference

12 December 2020

Hemodialysis removal of propafenone

1 reference

12 December 2020

In vitro protein binding of propafenone in normal and uraemic human sera

1 reference

12 December 2020

Beta-blocking and electrophysiological effects of propafenone in volunteers

1 reference

12 December 2020

Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs

1 reference

12 December 2020

Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment

1 reference

12 December 2020

Evaluation of the asthmogenicity of propafenone, a new antiarrhythmic drug. Comparison of spirometry with methacholine challenge

1 reference

12 December 2020

Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias

1 reference

12 December 2020

Propafenone for the treatment of refractory complex ventricular ectopic activity

1 reference

12 December 2020

A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes

1 reference

12 December 2020

Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone.

1 reference

12 December 2020

Different stereoselective effects of (R)- and (S)-propafenone: clinical pharmacologic, electrophysiologic, and radioligand binding studies

1 reference

12 December 2020

Stereoselective disposition and pharmacologic activity of propafenone enantiomers

1 reference

12 December 2020

In vitro characterization of the human cytochrome P-450 involved in polymorphic oxidation of propafenone

1 reference

12 December 2020

Nonlinear kinetics of propafenone metabolites in healthy man

1 reference

12 December 2020

Effects of propafenone on TEA-induced action potentials in vascular smooth muscle of canine coronary arteries

1 reference

12 December 2020

Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of propafenone during acute and chronic administration

1 reference

12 December 2020

Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia

1 reference

12 December 2020

Investigations on the pharmacokinetics of propafenone in man

1 reference

12 December 2020

The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone

1 reference

12 December 2020

Potent electrophysiologic effects of the major metabolites of propafenone in canine Purkinje fibers

1 reference

12 December 2020

Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone

1 reference

12 December 2020

10.2165/00003088-199121010-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

20 August 2017

0 references

1 reference